Sort
82,697 grants matching “vaccine development”
Region VIII Research Center for Excellence for Biodefen*
$9,869,569John T Belisle · Colorado State University · U54 · FY2007 · AI
Leadership for HIV/AIDS Clinical Trials Networks; HIV Vaccine Trials Network
$9,861,999Steven G. Self · Fred Hutchinson Cancer Research Center · U01 · FY2006 · AI
Northeast Biodefense Center
$9,860,235W. Ian Lipkin · Wadsworth Center · U54 · FY2006 · AI
The Malawi Clinical Trials Unit
$9,831,792Taha E Taha · Johns Hopkins University · U01 · FY2009 · AI
SERCEB Southeast Regional Centers of Excellence for Bio*
$9,829,455Duke University · U54 · FY2004 · AI
Development and Production of HIV Vaccines and Adjuvants
$9,825,620Jason Gall · National Institute Of Allergy And Infectious Diseases · ZIB · FY2021 · AI
NIAID-VRC- Rapid Manufacturing Response
$9,822,408David Lindsay · Leidos Biomedical Research, Inc. · N01 · FY2022 · AI
NIAID HIV and Other Infectious Diseases Clinical Research Support Services (CRSS)
$9,821,119Bambra Strokes · Ppd Development Lp · N01 · FY2020 · AI
Pacific-Southwest Ctr for Biodefense & Emerg Infect Dis*
$9,805,034Alan G. Barbour · University Of California-Irvine · U54 · FY2007 · AI
Pacific-Southwest Ctr for Biodefense & Emerg Infect Dis*
$9,796,830Alan G. Barbour · University Of California-Irvine · U54 · FY2006 · AI
REGIONAL PRIMATE RESEARCH CENTER
$9,789,737Oregon Health And Science University · P51 · FY2002 · RR
Bioterrorism: Molecular Analysis and Intervention
$9,786,645Olaf Schneewind · University Of Chicago · U54 · FY2008 · AI
SDMC - IMPAACT Leadership Group
$9,780,448David Eric Shapiro · Harvard School Of Public Health · UM1 · FY2017 · AI
BSL-3/ABSL-3 Expansion for Select Agent Translational Research
$9,774,453William M Pierce · University Of Louisville · C06 · FY2010 · RR
CoVPN 3005 - Efficacy, Immunogenicity, and Safety of SARS-CoV-2 Recombinant Protein Vaccine with Adjuvant in Adults 18 Years of Age and Older
$9,754,127Lawrence Corey · Fred Hutchinson Cancer Center · UM1 · FY2022 · AI
NIAID HIV and Other Infectious Diseases Clinical Research Support Services (CRSS)
$9,742,785Bambra Strokes · Ppd Development Lp · N01 · FY2023 · AI
The Malawi Clinical Trials Unit
$9,722,463Taha E Taha · Johns Hopkins University · U01 · FY2011 · AI
Adjuvant Development Program
$9,711,242Bradford Seamon · Dynavax Technologies Corporation · N01 · FY2011 · AI
Northeast Biodefense Center
$9,662,587W. Ian Lipkin · Columbia University Health Sciences · U54 · FY2009 · AI
EASTERN COOPERATIVE ONCOLOGY GROUP OPERATIONS OFFICE
$9,635,802Frontier Sci &Technology Rsch Fdn, Inc · U10 · FY2001 · CA
Pacific Southwest RCE for Biodefense & Emerging Infectious Diseases Research
$9,625,099Alan G. Barbour · University Of California-Irvine · U54 · FY2009 · AI
University of Washington Vaccine and Treatment Evaluation Unit
$9,616,028Anna Wald · University Of Washington · UM1 · FY2020 · AI
GYNECOLOGIC ONCOLOGY GROUP
$9,592,161Gynecologic Oncology Group · U10 · FY2003 · CA
DCTD Biopharmaceutical Development
$9,577,323David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2012 · CA
NIAID HIV and Other Infectious Diseases Clinical Research Support Services (CRSS)
$9,555,884Bambra Strokes · Ppd Development Lp · N01 · FY2022 · AI